In this 2020 introductory webinar “Cas-CLOVER: A Clean Alternative to CRISPR,” two experts present data on Cas-CLOVER fundamentals such as architecture, design and implementation in cells, yeast, plants as well as advanced gene editing in human T-cells for allogeneic CAR-T therapies. Thanks to GEN: Genetic Engineering and Biotechnology News for hosting.

Demeetra provides integrated genome engineering platforms, and products, backed by deep technical expertise.

Contact us to learn how our differentiated IP, flexible access models, and internal know-how can support adoption from discovery through bioprocessing and commercial use.